Загрузка...
S32. EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE ONCE-MONTHLY IN PATIENTS WITH SCHIZOPHRENIA WITH LOW, MODERATE, AND HIGH RECENT DISEASE ACTIVITY AT BASELINE
BACKGROUND: Paliperidone palmitate once-monthly (PP1M) is a long-acting injectable formulation that eliminates the need for daily dosing, ensures sustained plasma levels for several weeks, and helps clinicians reliably monitor adherence. We examined the efficacy and safety of PP1M in patients with s...
Сохранить в:
| Опубликовано в: : | Schizophr Bull |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455751/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz020.577 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|